2024-01-01 2024-12-31 false No description of principal activity Capium Accounts Production 1.1 11729612 2024-01-01 2024-12-31 11729612 bus:FullAccounts 2024-01-01 2024-12-31 11729612 bus:Micro-entities 2024-01-01 2024-12-31 11729612 bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 11729612 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 11729612 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 11729612 2024-01-01 2024-12-31 11729612 2024-12-31 11729612 bus:RegisteredOffice 2024-01-01 2024-12-31 11729612 core:WithinOneYear 2024-12-31 11729612 core:AfterOneYear 2024-12-31 11729612 1 2024-01-01 2024-12-31 11729612 bus:Director1 2024-01-01 2024-12-31 11729612 bus:Director1 2024-12-31 11729612 bus:Director1 2023-01-01 2023-12-31 11729612 2023-01-01 11729612 bus:LeadAgentIfApplicable 2024-01-01 2024-12-31 11729612 2023-01-01 2023-12-31 11729612 2023-12-31 11729612 core:WithinOneYear 2023-12-31 11729612 core:AfterOneYear 2023-12-31 11729612 bus:EntityAccountantsOrAuditors 2023-01-01 2023-12-31 11729612 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 11729612 core:CostValuation core:Non-currentFinancialInstruments 2023-12-31 11729612 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-12-31 11729612 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 11729612 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 11729612 core:Non-currentFinancialInstruments 2024-12-31 11729612 core:Non-currentFinancialInstruments 2023-12-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 11729612
England and Wales

 

 

 

BARIATRIC AND METABOLIC SURGERY UK


Unaudited Financial Statements
 


Period of accounts

Start date: 01 January 2024

End date: 31 December 2024
  2024   2023
    £ £   £ £
Current assets 87,552      54,601   
Net current assets   87,552      54,601 
Total assets less current liabilities   87,552      54,601 
Net assets   87,552      54,601 
 

         
Capital and reserves   87,553      54,601 
 
NOTES TO THE ACCOUNTS

General Information
Bariatric and Metabolic Surgery UK is a private company, limited by guarantee, registered in England and Wales, registration number 11729612, registration address 301 Third Floor Middlesex House, 130 College Road, Harrow, United Kingdom, HA1 1BQ.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Average number of employees

Average number of employees during the year was 0 (2023 : 0).

3.

Company Limited by Guarantee

The company is limited by guarantee and therefore has no shares.

For the year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 10 February 2025 and were signed by:


--------------------------------
Sanjay Agrawal
Director
1